What is a 'Second Request' in the context of the CVS Health and Signify Health acquisition?

A 'Second Request' is a formal request for additional information and documents from antitrust regulators (in this case, the U.S. Department of Justice) during their review of a merger or acquisition. It indicates that the regulators require a more in-depth investigation into the potential competitive effects of the transaction.

How does the 'Second Request' affect the timeline for the CVS Health acquisition of Signify Health?

The Second Request extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The waiting period will remain in effect until 30 days after both companies have substantially complied with the Second Request, or at a later date agreed upon with the DOJ. However, CVS Health still anticipates closing the transaction in the first half of 2023.

Does the 'Second Request' mean the acquisition is in jeopardy?

While a Second Request signifies a more detailed review and can delay the closing timeline, it does not necessarily mean the acquisition is in jeopardy. Many transactions receive Second Requests and are ultimately approved. CVS Health has stated it is cooperating with the DOJ and expects the deal to close as planned.

What is CVS Health's current outlook on the acquisition closing date?

Despite receiving the Second Request, CVS Health's management continues to anticipate that the transaction to acquire Signify Health will close in the first half of 2023.

CVS 8-K SEC Disclosure — Oct 20, 2022

Summary

CVS Health Corporation (CVS) has filed an 8-K report on October 20, 2022, providing an update on its proposed acquisition of Signify Health, Inc. The key development is that both CVS Health and Signify Health have received a 'Second Request' for additional information from the U.S. Department of Justice (DOJ) in connection with their antitrust review of the transaction. This Second Request, issued on October 19, 2022, extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. While this indicates a more thorough review by the DOJ, CVS Health has stated its commitment to continued cooperation and anticipates that the transaction will still close in the first half of 2023, as previously guided. Investors should monitor any further developments regarding the DOJ's review process and its potential impact on the closing timeline.

Key Highlights

1CVS Health and Signify Health received a Second Request for additional information from the DOJ on October 19, 2022.
2The Second Request is part of the DOJ's antitrust review of the proposed acquisition of Signify Health by CVS Health.
3The issuance of a Second Request extends the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
4CVS Health and Signify Health are cooperating with the DOJ's review.
5CVS Health reiterates its expectation for the transaction to close in the first half of 2023.
6The filing serves as an update on the regulatory approval process for the acquisition.

CVS HEALTH Corp 8-K Report, Corporate Update (Oct 20, 2022)

Summary

Key Highlights

Frequently Asked Questions